Business · 1 sources covering this

Emcure Pharma Q1: Net Profit Jumps 42%; CEO Satish Mehta Appointed As Chairman

At the operating front, earnings before interest, tax, depreciation and amortisation (Ebitda) surged 27.8% YoY to Rs 533 crore in Q1FY27, from Rs 417 crore in Q1FY26.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
Emcure Pharma Q1: Net Profit Jumps 42%; CEO Satish Mehta Appointed As Chairman
At the operating front, earnings before interest, tax, depreciation and amortisation (Ebitda) surged 27.8% YoY to Rs 533 crore in Q1FY27, from Rs 417 crore in Q1FY26.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/c23bdf5626352dcd5c8f77cc5bc6af02a1a33cf5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Emcure Pharma Q1: Net Profit Jumps 42%; CEO Satish Mehta Appointed As Chairman"></iframe>

Emcure Pharma Q1: Net Profit Jumps 42%; CEO Satish Mehta Appointed As Chairman

How 1 sources are covering this

Emcure Pharma Q1: Net Profit Jumps 42%; CEO Satish Mehta Appointed As Chairman

More from Business

Rupee falls 16 paise to close at 95.24 against U.S. dollar

Railway Board directs zones to speed up pending accident inquiries, cites delays in probes

Fiscal federalism, efficiency versus equity concerns

Telangana CM Reddy meets with US envoy Sergio Gor, invites investment in AI and life sciences

Reader

Trust & legal

Across the network